[302 Pages Report] Bioprocessing Analytics Equipment Market revenue is set to total US$ 485.1 Mn in 2022. The global market is expected to reach US$ 633.6 Mn by 2028, rising at a CAGR of 4.5%.
Attribute | Details |
---|---|
Global Bioprocessing Analytics Equipment Market Size (2022) | US$ 485.1 million |
Predicted Market Value (2028) | US$ 633.6 million |
Forecasted Growth Rate (2022-2028) | 4.3% CAGR |
Region with Highest Market Share | North America - 25.3% |
Bioprocessing analytics equipment demand accounts for 2.7% of the global biopharmaceutical equipment market. High demand for pharmaceutical manufacturing is expected to favour bioprocessing analytics equipment consumption over the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 4.54% |
H1, 2022 Projected | 4.55% |
H1, 2022 Outlook | 4.45% |
BPS Change - H1, 2022 (O) – H1, 2022 (P) | (-) 10 ↓ |
BPS Change – H1, 2022 (O) – H1, 2021 | (-) 09 ↓ |
As per the analysis by Future Market Insights, the variation between the BPS values observed within this market in H1, 2022 - outlook over H1, 2022 projected reflects a decline by 10 BPS. A decline in BPS growth in H1-2022 over H1-2021 by 09 Basis Point Share (BPS) is also demonstrated by the bioprocessing analytics equipment market.
The decline in the BPS values observed was attributed to the overall halt in the production and manufacturing capabilities during the mass lockdown impositions upon the advent of the global COVID-19 pandemic.
Conversely, through considerations in cost reduction during processes, consolidated bioprocessing approaches along with artificial intelligence and microfluidics are set to propel the process development in bioprocessing, thus promoting the growth of the overall industry.
The market is highly influenced by contract manufacturing dynamics, regulatory approvals, and licencing of therapeutics and biologics, under the impact of macro and industry factors. Key developments in the market include the development of Single-Use Systems (SUS) for bioprocessing, and bioremediation approaches for environmental sustainability.
Biomedical and biopharmaceutical industries have evolved exponentially over the past few years and increasing focus on creating better healthcare and medical ecosystem are expected to favor the demand for bioprocessing analytics equipment.
The market was valued at US$ 337 Mn and sales of bioprocessing analytics equipment rose at a CAGR of 4.1% for the market to attain a net valuation of US$ 463.2 Mn.
Rising demand for biotherapeutics, increasing demand for process optimization, rapid technological advancements, increasing research and development magnitude, and increasing scope of application in drug development and tissue engineering are some major factors that are expected to propel shipments of bioprocessing analytics equipment.
High cost of bioprocessing analytics equipment is expected to emerge as a major constraint in the global bioprocessing analytics equipment industry landscape. The demand for bioprocessing analytics equipment is projected to rise at a CAGR of 4.5% from 2022 to 2028.
“Increasing R&D and Drug Approvals to Fuel Market Growth Potential”
Research & development has seen an exponential increase over the past few years as the approval of new drugs has been increased by regulatory authorities such as the FDA (U.S. Food and Drug Administration). Increasing demand for the speedy development of new drugs and therapies has acted in favor of bioprocessing analytics equipment sales.
Increased research & development activity has encouraged bioprocessing analytics equipment manufacturers to launch new products to meet the increasing demand across the globe.
Since bioreactors have now become a staple in the bioprocessing industry, many companies have been rolling out new ones with larger capacities. The new bioreactors launched by Thermo Fisher are of capacities of 3000 liters and 5000 liters.
“High Costs and Stringent Regulatory Standards Majorly Hinder Market Growth”
High costs associated with bioprocessing analytics equipment are anticipated to be a major restraining factor in the global bioprocessing analytics equipment industry landscape. High costs restrict bioprocessing analytics equipment sales in less developed economies where spending potential is less.
Moreover, maintenance costs of bioprocessing analytics devices are also high which makes it even harder to afford while maintaining a budget for research and manufacturing operations.
Stringent regulatory norms and standards across the world make it difficult for bioprocessing analytics equipment manufacturers to create an evenly priced and distributed product for all. Which in turn creates an expensive product that is compliant with the standards of certain regions and countries. These factors are expected to restrain bioprocessing analytics equipment market potential.
“Increasing Focus on Healthcare to Drive Global Market Potential”
The bioprocessing analytics equipment industry analysis details the market stance across multiple regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).
Sales of bioprocessing analytics equipment in North America account for a dominant market share of 25.3% in 2022. Presence of key bioprocessing analytics equipment companies and advanced facilities in the region are expected to propel bioprocessing analytics system demand through 2028.
Increasing instances of diseases in Europe have led to a rise in research and development activities in the region which subsequently drives bioprocessing analytics equipment sales. The market for bioprocessing analytics equipment in Western Europe and Eastern Europe currently accounts for 21.5% and 5.4% of the global landscape.
On a cumulative note, East Asia, South Asia, and the Pacific regions are anticipated to see notable growth in bioprocessing analytics equipment market potential over the forecast period. Increased focus on healthcare and rising research on biotherapeutics and other pharmaceutical applications in emerging economies such as India and China is expected to drive market expansion in the aforementioned regions.
Demand for bioprocessing analytics equipment in the MEA region is predicted to rise at a steady pace as focus on healthcare increases and investments towards R&D activities increase in the region. Bioprocessing analytics system shipments in the MEA region account for 6.4% share of the global marketplace.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Increasing Focus on Healthcare and Biotherapeutics to Favour Market Growth”
India provides an extremely lucrative setting for bioprocessing analytics equipment manufacturers as the nation has opportunities for manufacturing as well as distribution at very low costs compared to most developed nations. Government initiatives to attract foreign investments make India a lucrative manufacturing market for bioprocessing analytics equipment suppliers.
Rising focus on healthcare and a developing healthcare infrastructure fuel the demand for R&D activities which in turn increase bioprocessing analytics equipment sales.
“Rising Healthcare Expenditure to Fuel Demand for Bioprocessing Analytics Equipment”
The U.S. is one of the most prominent markets for bioprocessing analytics equipment in the world. The presence of major bioprocessing analytics equipment companies in this country is an extremely important factor that influences the consumption of bioprocessing analytics equipment.
Advanced healthcare infrastructure, high healthcare expenditure and spending, high availability of advanced facilities and technologies, high production of biotherapeutics are some major factors that propel bioprocessing analytics device sales in this nation.
“Bioprocessing Analytics Equipment in Industrial Applications Predicted to Have Dominant Outlook”
Increase in demand for pharmaceutical products and rising need to enhance the manufacturing process are fueling the use of bioprocessing analytics equipment in industrial applications. Bioprocessing analytics equipment enables industries to enhance their manufacturing processes and eliminates the possibilities of error that are common in manual bioprocess monitoring techniques.
Demand for bioprocessing analytics equipment in clinical application is also expected to rise at a steady pace with increase in research and development activities across the world.
The pandemic of 2020 bolstered the focus on healthcare and gave further impetus to the already popular biopharmaceutical industry. Sales of bioprocessing analytics equipment saw a drop in 2020 due to restricted manufacturing activity and disruptions in supply chains across the globe.
Shipments of bioprocessing analytics equipment are expected to bounce back in the post-pandemic era as the world returns to normalcy and manufacturing activities resume to their full capacity.
Bioprocessing analytics equipment manufacturers are investing in mergers and acquisitions to broaden their product offerings and boosts sales across multiple regions. Investments to develop advanced bioprocess monitoring equipment is expected to be a prominent trend as manual monitoring is prone to error and is very labour-intensive.
Attribute | Details |
---|---|
Forecast Period | 2022-2028 |
Historical Data Available for | 2013-2021 |
Market Analysis | US$ million for Value |
Key Regions Covered |
|
Key Countries Covered |
|
Key Market Segments Covered |
|
Key Companies Profiled |
|
Pricing | Available upon Request |
By Product Type :
By Application :
By End User :
By Region :
The global bioprocessing analytics equipment market rose at a CAGR of 4.1% and ended up with a valuation of US$ 463.2 Mn in 2021.
The bioprocessing analytics equipment market in Japan accounts for a market share of 7.6% in the global bioprocessing analytics equipment industry.
Bioprocessing analytics equipment sales are estimated to be worth US$ 633.6 Mn by the end of 2028.
Bioprocessing analytics equipment consumption is anticipated to rise at a CAGR of 4.5% from 2022 to 2028.
In 2022, the global bioprocessing analytics equipment market holds a valuation of US$ 485.1 Mn.
1. Executive Summary 1.1. Market Overview 1.2. Market Analysis 1.3. FMI Analysis and Recommendations 1.4. Wheel of Fortune 2. Market Introduction 2.1. Market Taxonomy 2.2. Market Definition 3. Bioprocessing Analytics Equipment Market Opportunity Analysis 3.1. Macro-Economic Factors 3.2. Opportunity Analysis 4. Market Background 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Supply Side Drivers 4.1.1.2. Demand Side Drivers 4.1.2. Restraints 4.1.3. Trends 5. Global Economic Outlook 5.1. Gross Domestic Product by Region & Country, 2013 – 2021 6. Key Inclusions 6.1. Key Distributors List 6.2. Regulatory Scenario 6.3. Pricing Analysis 7. North America Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028 7.1. Introduction 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 7.2.1. U.S. 7.2.2. Canada 7.3. Market Size (US$ Mn) Forecast By Country, 2022–2028 7.3.1. U.S. 7.3.2. Canada 7.4. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021 7.4.1. Osmometers 7.4.1.1. Vapor Pressure Depression Osmometers 7.4.1.2. Membrane Osmometers 7.4.1.3. Freezing Point Depression Osmometers 7.4.2. Bioprocess Analyzers 7.5. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028 7.6. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 7.6.1. Clinical Application 7.6.2. Industrial Application 7.7. Market Size (US$ Mn) Forecast By Application, 2022–2028 7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 7.8.1. Biopharmaceutical Companies 7.8.2. Contract Research Organizations (CROs) 7.8.3. Contract Manufacturing Organizations (CMOs) 7.8.4. Academics & Research Institutes 7.9. Market Attractiveness Analysis 7.9.1. By Country 7.9.2. By Product Type 7.9.3. By Application 7.9.4. By End User 7.10. Key Market Participants – Intensity Mapping 7.11. Drivers and Restraints: Impact Analysis 8. Western Europe Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028 8.1. Introduction 8.2. Regional Market Trends 8.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 8.3.1. Germany 8.3.2. U.K 8.3.3. France 8.3.4. Italy 8.3.5. Spain 8.3.6. Rest of Western Europe 8.4. Market Size (US$ Mn) Forecast By Country, 2022–2028 8.4.1. Germany 8.4.2. U.K 8.4.3. France 8.4.4. Italy 8.4.5. Spain 8.4.6. Rest of Western Europe 8.5. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021 8.5.1. Osmometers 8.5.1.1. Vapor Pressure Depression Osmometers 8.5.1.2. Membrane Osmometers 8.5.1.3. Freezing Point Depression Osmometers 8.5.2. Bioprocess Analyzers 8.6. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028 8.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 8.7.1. Clinical Application 8.7.2. Industrial Application 8.8. Market Size (US$ Mn) Forecast By Application, 2022–2028 8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 8.9.1. Biopharmaceutical Companies 8.9.2. Contract Research Organizations (CROs) 8.9.3. Contract Manufacturing Organizations (CMOs) 8.9.4. Academics & Research Institutes 8.10. Market Attractiveness Analysis 8.10.1. By Country 8.10.2. By Product Type 8.10.3. By Application 8.10.4. By End User 8.11. Key Market Participants – Intensity Mapping 8.12. Drivers and Restraints: Impact Analysis 9. Eastern Europe Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028 9.1. Introduction 9.2. Regional Market Trends 9.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 9.3.1. Russia 9.3.2. Poland 9.3.3. Rest of Eastern Europe 9.4. Market Size (US$ Mn) Forecast By Country, 2022–2028 9.4.1. Russia 9.4.2. Poland 9.4.3. Rest of Eastern Europe 9.5. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021 9.5.1. Osmometers 9.5.1.1.1. Vapor Pressure Depression Osmometers 9.5.1.1.2. Membrane Osmometers 9.5.1.1.3. Freezing Point Depression Osmometers 9.5.2. Bioprocess Analyzers 9.6. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028 9.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 9.7.1. Clinical Application 9.7.2. Industrial Application 9.8. Market Size (US$ Mn) Forecast By Application, 2022–2028 9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 9.9.1. Biopharmaceutical Companies 9.9.2. Contract Research Organizations (CROs) 9.9.3. Contract Manufacturing Organizations (CMOs) 9.9.4. Academics & Research Institutes 9.10. Market Attractiveness Analysis 9.10.1. By Country 9.10.2. By Product Type 9.10.3. By Application 9.10.4. By End User 9.11. Key Market Participants – Intensity Mapping 9.12. Drivers and Restraints: Impact Analysis 10. Latin America Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028 10.1. Introduction 10.2. Regional Market Trends 10.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 10.3.1. Brazil 10.3.2. Mexico 10.3.3. Rest of Latin America 10.4. Market Size (US$ Mn) Forecast By Country, 2022–2028 10.4.1. Brazil 10.4.2. Mexico 10.4.3. Rest of Latin America 10.5. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021 10.5.1. Osmometers 10.5.1.1. Vapor Pressure Depression Osmometers 10.5.1.2. Membrane Osmometers 10.5.1.3. Freezing Point Depression Osmometers 10.5.2. Bioprocess Analyzers 10.6. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028 10.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 10.7.1. Clinical Application 10.7.2. Industrial Application 10.8. Market Size (US$ Mn) Forecast By Application, 2022–2028 10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 10.9.1. Biopharmaceutical Companies 10.9.2. Contract Research Organizations (CROs) 10.9.3. Contract Manufacturing Organizations (CMOs) 10.9.4. Academics & Research Institutes 10.10. Market Attractiveness Analysis 10.10.1. By Country 10.10.2. By Product Type 10.10.3. By Application 10.10.4. By End User 10.11. Key Market Participants – Intensity Mapping 10.12. Drivers and Restraints: Impact Analysis 11. Asia Pacific Excluding China & Japan Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 11.3.1. India 11.3.2. Australia and New Zealand 11.3.3. ASEAN 11.3.4. Rest of APECJ 11.4. Market Size (US$ Mn) Forecast By Country, 2022–2028 11.4.1. India 11.4.2. Australia and New Zealand 11.4.3. ASEAN 11.4.4. Rest of APECJ 11.5. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021 11.5.1. Osmometers 11.5.1.1. Vapor Pressure Depression Osmometers 11.5.1.2. Membrane Osmometers 11.5.1.3. Freezing Point Depression Osmometers 11.5.2. Bioprocess Analyzers 11.6. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028 11.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 11.7.1. Clinical Application 11.7.2. Industrial Application 11.8. Market Size (US$ Mn) Forecast By Application, 2022–2028 11.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 11.9.1. Biopharmaceutical Companies 11.9.2. Contract Research Organizations (CROs) 11.9.3. Contract Manufacturing Organizations (CMOs) 11.9.4. Academics & Research Institutes 11.10. Market Attractiveness Analysis 11.10.1. By Country 11.10.2. By Product Type 11.10.3. By Application 11.10.4. By End User 11.11. Key Market Participants – Intensity Mapping 11.12. Drivers and Restraints: Impact Analysis 12. China Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028 12.1. Introduction 12.2. Regional Trends 12.3. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021 12.3.1. Osmometers 12.3.1.1. Vapor Pressure Depression Osmometers 12.3.1.2. Membrane Osmometers 12.3.1.3. Freezing Point Depression Osmometers 12.3.2. Bioprocess Analyzers 12.4. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028 12.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 12.5.1. Clinical Application 12.5.2. Industrial Application 12.6. Market Size (US$ Mn) Forecast By Application, 2022–2028 12.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 12.7.1. Biopharmaceutical Companies 12.7.2. Contract Research Organizations (CROs) 12.7.3. Contract Manufacturing Organizations (CMOs) 12.7.4. Academics & Research Institutes 12.8. Market Attractiveness Analysis 12.8.1. By Product Type 12.8.2. By Application 12.8.3. By End User 12.9. Key Market Participants – Intensity Mapping 12.10. Drivers and Restraints: Impact Analysis 13. Japan Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028 13.1. Introduction 13.2. Regional Trends 13.3. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021 13.3.1. Osmometers 13.3.1.1. Vapor Pressure Depression Osmometers 13.3.1.2. Membrane Osmometers 13.3.1.3. Freezing Point Depression Osmometers 13.3.2. Bioprocess Analyzers 13.4. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028 13.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 13.5.1. Clinical Application 13.5.2. Industrial Application 13.6. Market Size (US$ Mn) Forecast By Application, 2022–2028 13.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 13.7.1. Biopharmaceutical Companies 13.7.2. Contract Research Organizations (CROs) 13.7.3. Contract Manufacturing Organizations (CMOs) 13.7.4. Academics & Research Institutes 13.8. Market Attractiveness Analysis 13.8.1. By Product Type 13.8.2. By Application 13.8.3. By End User 13.9. Key Market Participants – Intensity Mapping 13.10. Drivers and Restraints: Impact Analysis 14. Middle East and Africa Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028 14.1. Introduction 14.2. Regional Market Trends 14.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 14.3.1. GCC Countries 14.3.2. South Africa 14.3.3. Rest of MEA 14.4. Market Size (US$ Mn) Forecast By Country, 2022–2028 14.4.1. GCC Countries 14.4.2. South Africa 14.4.3. Rest of MEA 14.5. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021 14.5.1. Osmometers 14.5.1.1. Vapor Pressure Depression Osmometers 14.5.1.2. Membrane Osmometers 14.5.1.3. Freezing Point Depression Osmometers 14.5.2. Bioprocess Analyzers 14.6. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028 14.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2021 14.7.1. Clinical Application 14.7.2. Industrial Application 14.8. Market Size (US$ Mn) Forecast By Application, 2022–2028 14.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 14.9.1. Biopharmaceutical Companies 14.9.2. Contract Research Organizations (CROs) 14.9.3. Contract Manufacturing Organizations (CMOs) 14.9.4. Academics & Research Institutes 14.10. Market Attractiveness Analysis 14.10.1. By Country 14.10.2. By Product Type 14.10.3. By Application 14.10.4. By End User 14.11. Key Market Participants – Intensity Mapping 14.12. Drivers and Restraints: Impact Analysis 15. Forecast Factors: Relevance and Impact 16. Market Structure Analysis 16.1. Market Structure by Tier 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competitors Deep Dive 17.2.1. Thermo Fisher Scientific Inc. 17.2.1.1. Overview 17.2.1.2. Product and Application Portfolio 17.2.1.3. Production Footprint 17.2.1.4. Sales Footprint 17.2.1.5. Channel Footprint 17.2.1.6. Strategy 17.2.1.6.1.1. Marketing Strategy 17.2.1.6.1.2. Product Strategy 17.2.1.6.1.3. Channel Strategy 17.2.2. F. Hoffmann-La Roche Ltd. (Roche Diagnostics) 17.2.2.1. Overview 17.2.2.2. Product and Application Portfolio 17.2.2.3. Production Footprint 17.2.2.4. Sales Footprint 17.2.2.5. Channel Footprint 17.2.2.6. Strategy 17.2.2.6.1.1. Marketing Strategy 17.2.2.6.1.2. Product Strategy 17.2.2.6.1.3. Channel Strategy 17.2.3. ELITechGroup 17.2.3.1. Overview 17.2.3.2. Product and Application Portfolio 17.2.3.3. Production Footprint 17.2.3.4. Sales Footprint 17.2.3.5. Channel Footprint 17.2.3.6. Strategy 17.2.3.6.1.1. Marketing Strategy 17.2.3.6.1.2. Product Strategy 17.2.3.6.1.3. Channel Strategy 17.2.4. KNAUER 17.2.4.1. Overview 17.2.4.2. Product and Application Portfolio 17.2.4.3. Production Footprint 17.2.4.4. Sales Footprint 17.2.4.5. Channel Footprint 17.2.4.6. Strategy 17.2.4.6.1.1. Marketing Strategy 17.2.4.6.1.2. Product Strategy 17.2.4.6.1.3. Channel Strategy 17.2.5. Gonotec GmbH 17.2.5.1. Overview 17.2.5.2. Product and Application Portfolio 17.2.5.3. Production Footprint 17.2.5.4. Sales Footprint 17.2.5.5. Channel Footprint 17.2.5.6. Strategy 17.2.5.6.1.1. Marketing Strategy 17.2.5.6.1.2. Product Strategy 17.2.5.6.1.3. Channel Strategy 17.2.6. Advanced Instruments Inc. 17.2.6.1. Overview 17.2.6.2. Product and Application Portfolio 17.2.6.3. Production Footprint 17.2.6.4. Sales Footprint 17.2.6.5. Channel Footprint 17.2.6.6. Strategy 17.2.6.6.1.1. Marketing Strategy 17.2.6.6.1.2. Product Strategy 17.2.6.6.1.3. Channel Strategy 17.2.7. Resolution Spectra Systems Inc. 17.2.7.1. Overview 17.2.7.2. Product and Application Portfolio 17.2.7.3. Production Footprint 17.2.7.4. Sales Footprint 17.2.7.5. Channel Footprint 17.2.7.6. Strategy 17.2.7.6.1.1. Marketing Strategy 17.2.7.6.1.2. Product Strategy 17.2.7.6.1.3. Channel Strategy 17.2.8. Kaiser Optical Systems, Inc. 17.2.8.1. Overview 17.2.8.2. Product and Application Portfolio 17.2.8.3. Production Footprint 17.2.8.4. Sales Footprint 17.2.8.5. Channel Footprint 17.2.8.6. Strategy 17.2.8.6.1.1. Marketing Strategy 17.2.8.6.1.2. Product Strategy 17.2.8.6.1.3. Channel Strategy 17.2.9. SYSBIOTECH SARL 17.2.9.1. Overview 17.2.9.2. Product and Application Portfolio 17.2.9.3. Production Footprint 17.2.9.4. Sales Footprint 17.2.9.5. Channel Footprint 17.2.9.6. Strategy 17.2.9.6.1.1. Marketing Strategy 17.2.9.6.1.2. Product Strategy 17.2.9.6.1.3. Channel Strategy 18. Global Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028 By Region 18.1. Introduction / Key Findings 18.2. Historical Market Size (US$ Mn) Analysis By Region 18.2.1. North America 18.2.2. Western Europe 18.2.3. Eastern Europe 18.2.4. Latin America 18.2.5. Asia Pacific Excluding Japan And China 18.2.6. China 18.2.7. Japan 18.2.8. Middle East and Africa 18.3. Market Size (US$ Mn) Forecast By Region 18.3.1. North America 18.3.2. Western Europe 18.3.3. Eastern Europe 18.3.4. Latin America 18.3.5. Asia Pacific Excluding Japan And China 18.3.6. China 18.3.7. Japan 18.3.8. Middle East and Africa 18.4. Market Attractiveness Analysis By Region 19. Global Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028, By Product Type 19.1. Introduction/Key Finding 19.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2013-2021 19.2.1. Osmometers 19.2.1.1. Vapor Pressure Depression Osmometers 19.2.1.2. Membrane Osmometers 19.2.1.3. Freezing Point Depression Osmometers 19.2.2. Bioprocess Analyzers 19.3. Market Size (US$ Mn) & Volume Forecast By Product Type, 2022–2028 19.4. Market Attractiveness Analysis By Product Type 20. Global Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028, By Application 20.1. Introduction/Key Finding 20.2. Historical Market Size (US$ Mn) Analysis By Application, 2013-2021 20.2.1. Clinical Application 20.2.2. Industrial Application 20.3. Market Size (US$ Mn) Forecast By Application, 2022–2028 20.4. Market Attractiveness Analysis By Application 21. Global Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028, By End User 21.1. Introduction/Key Finding 21.2. Historical Market Size (US$ Mn) Analysis By End User, 2013-2021 21.2.1. Biopharmaceutical Companies 21.2.2. Contract Research Organizations (CROs) 21.2.3. Contract Manufacturing Organizations (CMOs) 21.2.4. Academics & Research Institutes 21.3. Market Size (US$ Mn) Forecast By End User, 2022–2028 21.4. Market Attractiveness Analysis By End User 22. Global Bioprocessing Analytics Equipment Market Analysis 2013-2021 and Forecast 2022–2028 22.1. Market Value Share Analysis By All Segment 22.2. Y-o-Y Growth Analysis By All Segment 22.3. Absolute $ Opportunity 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports